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Abstract
Background:  Our investigation sought to compare changes in sexual function following
supracervical hysterectomy (SCH) and total abdominal hysterectomy (TAH).
Methods: A retrospective chart review was performed to identify all patients who underwent
supracervical hysterectomy or total abdominal hysterectomy at a tertiary care center. Patients who
met criteria for participation were sent a one page confidential, anonymous questionnaire to assess
sexual function experienced both pre- and postoperatively. A total of 69 patients in each group
were eligible for participation. A multiple logistic regression model was used to analyze measured
variables.
Results: Forty-eight percent (n = 33) of women undergoing a SCH returned the questionnaire,
while 39% (n = 27) of those undergoing a TAH chose to participate. There were no significant
demographic differences between the two groups. Patients who underwent TAH reported worse
postoperative sexual outcome than SCH patients with respect to intercourse frequency, orgasm
frequency and overall sexual satisfaction (P = 0.01, 0.03, and 0.03, respectively). Irrespective of type
of hysterectomy, 35% of patients who underwent bilateral salpingoophorectomy (BSO) with
hysterectomy experienced worse overall sexual satisfaction compared to 3% of patients who
underwent hysterectomy alone (P = 0.02).
Conclusions: Our data suggest that TAH patients experienced worse postoperative sexual
function than SCH patients with respect to intercourse frequency and overall sexual satisfaction.
Irrespective of type of hysterectomy, patients who underwent bilateral salpingoophorectomy
experienced worse overall sexual satisfaction.
Introduction
Hysterectomy is the most common gynecologic operation
performed in the United States. It is estimated that by the
age of 65, 1 of 3 women will have undergone a hysterec-
tomy [1,2]. Current practice in the United States strongly
favors total abdominal hysterectomy (TAH) over suprac-
Published: 17 January 2002
BMC Women's Health 2002, 2:1
Received: 17 September 2001
Accepted: 17 January 2002
This article is available from: http://www.biomedcentral.com/1472-6874/2/1
© 2002 Saini et al; licensee BioMed Central Ltd. Verbatim copying and redistribution of this article are permitted in any medium for any purpose, 
provided this notice is preserved along with the article's original URL.BMC Women's Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/1
Page 2 of 7
(page number not for citation purposes)
ervical hysterectomy (SCH) for benign gynecologic dis-
ease. However, there has been a small but steady rise in
the number of supracervical hysterectomies performed
both regionally and nationally [3,4]. The reasons for this
shift in hysterectomy type are multifactorial and poorly
understood, but may reflect changing attitudes on the part
of both patients and surgeons favoring less invasive oper-
ations. Potential advantages of SCH over TAH include de-
creased operative morbidity and reduced risk of urinary
and sexual dysfunction [5–10]. Patient concerns about
sexual functioning after hysterectomy may also play a role
in the decision to undergo a supracervical hysterectomy
versus total abdominal hysterectomy.
Various mechanisms have been proposed to explain why
cervical conservation (SCH) may have a less detrimental
effect on sexual function than TAH. Early pioneering work
from the 1960's [11] described elevation of both cervix
and uterus during the excitement and plateau phase fol-
lowed by fundal uterine contractions progressively involv-
ing the lower uterine segment as orgasm developed.
Cervical os dilatation occurred immediately afterwards,
implicating a role for the cervix in the female sexual re-
sponse.
Another theory postulates that the ability to achieve inter-
nal orgasm depends on the stimulation of nerve endings
of the uterovaginal (cervical) plexus of Frankenhauser
[6,12]. This plexus is a matrix of afferent nerve fibers inti-
mately surrounding the cervix. Stimulation of the cervix
may contribute to a pleasurable sensation, ultimately ex-
perienced as orgasm. Excision of the cervix that occurs
during TAH necessarily results in the loss of a major por-
tion of this plexus.
Studies examining sexual function after hysterectomy are
contradictory and the controversy surrounding this topic
is not new. Several investigators have reported a measura-
ble decrease in sexual response after total abdominal hys-
terectomy [13–16] while others have found sexual
functioning improved after hysterectomy [17,18]. Data re-
garding sexual function after an aggregation of all types of
hysterectomy (TAH, SCH, vaginal and laparoscopy assist-
ed vaginal hysterectomy) are especially difficult to inter-
pret [18]. One intuitive mechanism to account for
improved sexual functioning post hysterectomy is the re-
lief from dyspareunia caused by excision of uterine pa-
thology (i.e., fibroids, menorrhagia).
Although there have been many studies exploring the gen-
eral impact of total hysterectomy on sexual function, few
have compared particular types of hysterectomy and their
associated effect on subsequent sexual function. Indeed,
only one investigator to date has explicitly examined the
effect of type of hysterectomy (SCH versus TAH) on sexual
function [9,13]. A statistically significant reduction in or-
gasm frequency among TAH patients when compared to
SCH was reported in this population [13]. Ours is the first
investigation in over a decade to offer a comparative anal-
ysis of sexual response as a function of hysterectomy type
(SCH versus TAH).
Methods
A retrospective review was conducted of all patients who
had undergone a TAH or SCH at The New York-Presbyte-
rian Hospital Weill Medical College of Cornell University
from January 1, 1994 to December 31, 1994. Patients with
a diagnosis of cancer (gynecologic or non-gynecologic),
psychiatric illness, neurologic disease, diabetes, chronic
pelvic pain, endometriosis or a debilitating medical con-
dition were excluded. Patients greater than age sixty and
non-English speaking patients were excluded. Institution-
al review board approval was obtained before data collec-
tion.
A total of 333 hysterectomy patients were identified for
the study period, and 160 of these did not meet criteria for
participation as defined above. An additional 17 charts
could not be located. This resulted in 156 patients eligible
for inclusion in the study. Demographic data were ob-
tained from the chart review of these patients and were en-
tered into a computer database.
All hysterectomies were performed intrafascially using the
clamp-cut-ligate method as described previously [19]. For
SCH patients, the corpus was amputated below the level
of the internal cervical os. The cervical stump was closed
using interrupted No. 0 delayed absorbable suture (Poly-
glactin 910).
Patients were sent a confidential questionnaire developed
by a multidisciplinary team comprised of psychiatrists,
statisticians, gynecologists, pathologists and a sexual ther-
apist. It was pretested on a group of hysterectomy patients
identified from a 1993 chart review at the same institu-
tion. Patient response and feedback from that survey re-
Table 1: Outcome variables measured by questionnaire
Sexual variable Response choices
libido (desire) absent, moderate, strong
frequency of intercourse (per month) 0, 1–3, 4–6, 7–9, >10
dyspareunia (thrusting pain)
porgasm frequency (ability to achieve 
orgasm)
 multiple orgasm
never, infrequently, fre-
quently, always
overall sexual satisfaction worse, unchanged, betterBMC Women's Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/1
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sulted in the questionnaire being modified and
condensed to one page. In its final form, the survey in-
cluded 16 questions evaluating demographic data and
measuring the following sexual variables: libido (desire),
frequency of intercourse, dyspareunia, orgasm frequency,
multiple orgasm frequency and overall sexual satisfaction.
All questions were in a multiple-choice format although
patients were allowed to add additional comments. In the
questionnaire, patients were asked to describe their sexual
function before and after their operation in absolute rath-
er than relative terms in order to minimize recall bias (Ta-
ble 1). Preoperative to postoperative change was then
determined for each sexual variable and recorded as "bet-
ter", "unchanged", or "worse". For example, a patient who
preoperatively reported her frequency of intercourse (per
month) as 1–3 and postoperatively as 4–6 was identified
as "better". Non-respondents were sent a second mailing
approximately one month later. After this second ques-
tionnaire, no further attempt was made to contact pa-
tients. Patients who did not wish to participate in the
study could so indicate, and they were not contacted fur-
ther.
Table 2: Group characteristics
SCH (n = 33) TAH (n = 27) Significance
Age (mean, +/- SD) 45+/-5.0 46+/-4.8 NS*
Race
white 21(64) 16(59)
black 6(18) 6(22) NS
hispanic 3(9) 5(19)
asian 3(9) 0
Marital status
married 19(58) 19 (70)
single 8(24) 6(23) NS
divorced 6(18) 2(7)
Length of stay (days)
(mean, +/- SD)
4.3+/-1.5 4.7+/-1.8 NS*
Uterine mass (grams)
(mean, +/- SD)
665+/-766 400+/-273 NS*
Indications
leiomyoma 26(79) 16(60)
menometrorhagia 3(9) 6(22) NS
cyst 3(9) 3(11)
other 1 (3) 2 (7)
Incision type
pfannensteil 25 (76) 23(85) NS
vertical 8(24) 4(15)
Previous abdominal surgery
yes 17 (52) 10(37) NS
no 16(48) 17(63)
Parity
parous 25 (76) 20(74) NS
nonparous 8(14) 7(16)
Same partner
yes 27(84) 19 (79) NS
no 5(16) 5(21)
Oophorectomy
yes 10(30) 17(63) p < 0.05
no 23(70) 10(37)
Hormone replacement
yes 12(36) 16(59) NS
no 21 (64) 11 (41)
Data are presented as n (%); NS = not significant; chi square test; NS* students t testBMC Women's Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/1
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Data were analyzed using the JMP statistical package (ver-
sion 3.2.2 SAS Institute; Carey, North Carolina USA). Chi-
square or Student's-t test was used to evaluate categorical
or continuous demographic data and preoperative sexual
function variables, as appropriate. A multiple logistic re-
gression model was used to analyze independent predic-
tor variables. Percent distributions were calculated for all
variables. Statistical significance was defined as P < 0.05.
Results
The patient-partitioning schema for the study population
is shown in Figure 1. The proportion of responders was
not significantly different between the two surgical sub-
groups (Table 2). Forty-eight percent (n = 33) of women
undergoing a SCH returned the questionnaire, while 39%
(n = 27) of those undergoing a TAR chose to participate.
While all respondents answered the majority of questions,
not all study patients answered every question. Nonethe-
less, there was no question in the survey answered by few-
er than 74% of the respondents. The mean time (+SD)
from surgery to questionnaire was 19.2 months (± 3.4
months) in the SCH group and 19.8 months (± 3.9
months) in the TAH group (range = 14–26 months; P >
0.05).
The demographic data obtained from the chart review and
from the questionnaire are summarized in Table 2. The
data illustrate that the two groups do not differ signifi-
cantly except for oophorectomy status. Significantly more
women underwent bilateral salpingoophorectomy (BSO)
in the TAH group than in the SCH group (63 percent ver-
sus 30 percent, respectively; P < 0.05). Since removal of
the ovaries may have a deleterious effect on sexual func-
tion [20], the possible effects of oophorectomy on out-
come measures were considered in the analysis. In
addition, we considered the possible effects of hormone
replacement therapy (HRT) of current users on sexual
function, even though the two surgical groups showed no
significant difference in reported use of HRT.
Outcome variables in which a pre-surgical subjective rat-
ing was elicited were evaluated and compared between
the two groups (Table 3). In the TAH group, three women
reported the absence of intercourse before surgery (versus
no women in the SCH group), while in the SCH group
proportionately more women reported intercourse >6
times/month. Although the possible effect of this finding
on our ultimate outcomes was unclear, we included it as a
possible confounder in our subsequent modeling process
to insure that the results were not biased. We also added
consideration of prior expectations regarding the likely ef-
fect of the surgery on sexual function, in an attempt to
control for as many potential confounding variables as
possible.
The results of our initial analysis led to the construction of
a multiple stepwise logistic regression model in which
type of procedure, oophorectomy, use of HRT, frequency
of intercourse prior to surgery, and preoperative expecta-
tions were used to predict the various sexual function out-
come measures. Since our hypothesis centered on loss of
sexual function, each of the outcome measures was cate-
gorized according to a binomial classification of function
relative to pre-surgical status.
The relevant findings of this modeling procedure are sum-
marized in Table 4. Changes in libido, dyspareunia, and
multiple orgasm frequency were not predictable based
upon any of our independent variables. However, inter-
course frequency, orgasm frequency, and overall sexual
satisfaction were all significantly related to type of proce-
dure (P = 0.01, 0.03, and 0.03, respectively). Regarding in-
tercourse frequency, 42% (n = 10) of TAH patients
experienced worse outcome compared with 15% (n = 5)
of SCH patients. Forty-three percent (n = 9) of TAH pa-
tients experienced a decrease in the ability to achieve or-
gasm compared with 6% (n = 2) of SCH patients. Overall
sexual satisfaction was worse for 33% (n = 8) of TAH pa-
tients compared with 6% (n = 2) of SCH patients. Only for
overall sexual satisfaction did oophorectomy add signifi-
cant predictive value (P = 0.02). Thirty-five percent (n = 9)
of patients who had a BSO with their hysterectomy had
worse overall sexual satisfaction when compared to 3% (n
= 1) of patients who had hysterectomy only without BSO.
Figure 1BMC Women's Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/1
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Table 3: Baseline (preoperative) sexual function & expectations
SCH TAH Significance
Libido (desire)
absent 1 (3) 2(8)
moderate 21 (64) 18 (72) NS
strong 11 (33) 5(20)
Dyspareunia
never 19 (58) 8(35)
infrequently 7(21) 8(35) NS
frequently 6(18) 5(22)
always 1 (3) 2 (9)
Multiple Orgasm
never 8(26) 4(17)
infrequently 9(29) 9(37) NS
frequently 10 (32) 10 (42)
always 4(13) 1 (4)
Intercourse frequency (per month)
0 0 3(12)
1–3 11 (33) 4(16)
4–6 8 (24) 13 (52) p < 0.05
7–9 8(24) 2(8)
>10 6(18) 3(12)
Orgasm frequency
never 1 (3) 0
infrequently 5(16) 4(17) NS
frequently 18 (58) 12 (52)
always 7(23) 7(30)
Expectations
worse 13 (39) 5(22)
unchanged 18 (55) 15 (65) NS
better 2(6) 3(13)
Data are presented as n (%); Not all patients answered every question; NS = not significant, chi square test
Table 4: Sexual function results
Hysterectomy BSO HRT
SCH
 (N = 33)
TAH
(N = 27)
OR
95% CI
+ 
(N = 27)
- 
(N = 33)
+ 
(N = 28)
- 
(N = 32)
Libido
same/better 27(87) 17(68) 3.2 16(64) 28(90) 19(70) 26(87)
worse 4(13) 8(32) (0.8–12.2) 9(36) 3(10) 8(30) 4(13)
Dyspareunia
same/better 30(91) 18(90) 1.1 22(92) 27(90) 24(92) 25(89)
worse 3(9) 2(10) (0.2–7.3) 2(8) 3(10) 2(8) 3(11)
Multiple orgasm
same/better 29(91) 16(73) 7.8 16(67) 29(97) 19(73) 26(93)
worse 3(9) 6(27) (1.5–40.9) 8(33) 1(3) 7(27) 2(7)
Intercourse frequency
same/better 28(85) 14(58)* 3.6 19(73) 23(74) 20(74) 22(73)
worse 5(15) 10(42) (0.8–16.5) 7(27) 8(26) 7(26) 8(27)BMC Women's Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/1
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With respect to HRT, there was no significant difference
between sexual function of patients who were receiving
hormone replacement and those who were not. Frequen-
cy of intercourse prior to surgery was not associated with
postoperative change in any of the sexual variables ana-
lyzed (P < 0.05).
Discussion
The results presented here support a role for the cervix in
the female sexual response. In particular, our finding of a
statistically significant decrease in the ability to achieve
orgasm among TAH patients when compared to SCH pa-
tients (43% vs. 6%, P = 0.03) is noteworthy. Our results
support and expand upon the work by Kilkku [13] who re-
ported a greater reduction in orgasm following TAH when
compared to SCH (P < 0.05).
If patients derive less satisfaction from sexual intercourse
by experiencing a reduction in their ability to achieve or-
gasm, then the frequency of intercourse might decrease.
Indeed, in this study population both frequency of inter-
course and overall sexual satisfaction were worse among
TAH patients when compared to SCH patients. Previous
investigators [14] found that 37% of patients after TAH/
BSO had a reduction in frequency of intercourse, similar
to the 42% in our study group. The decline in overall sex-
ual response after hysterectomy in our population was
also consistent with results published by others [15,16].
Dyspareunia was the only sexual variable where the re-
sults after surgery revealed no trend favoring SCH. Nine
percent (n = 3) of SCH patients and 10% (n = 2) of TAH
patients experienced worsening of dyspareunia after the
operation. Sixty six percent of TAH patients and 42% of
SCH patients experienced some degree of dyspareunia pri-
or to surgery. Perhaps the dyspareunia was caused by in-
trauterine pathology, such as leiomyoma. Since uterine
leiomyoma was the main indication for hysterectomy in
79% of SCH patients and 60% of TAH patients, hysterec-
tomy could have resulted in a similar reduction of pain in
the two groups. That hysterectomy (SCH or TAH) is asso-
ciated with improvement in dyspareunia supports the
findings of others [9,18,21,22].
Although the two surgical groups in this study are very
similar, they do differ with respect to intercourse frequen-
cy and BSO status (Table  2 and 3). Because the independ-
ent variable in the statistical model was change in
frequency of intercourse (postoperative frequency minus
preoperative frequency) and not the magnitude of inter-
course frequency, this disparity in the preoperative charac-
teristics does not adversely impact our findings. Indeed,
realizing that a sexual frequency of zero cannot become
worse, this may have in fact biased the results in favor of
the TAH cohort.
As demonstrated in the literature, the analysis of the rela-
tionship of BSO and postoperative sexual function is com-
plex. Although one investigator reported no difference in
libido between patients who underwent TAH and TAH/
BSO [15], our data are consistent with the findings of a
more recent investigation [20] where BSO status did influ-
ence sexual outcome in the study population.
In accord with previous investigations [14,15], we deter-
mined that HRT did not affect sexual outcome in any of
the variables tested although the majority (86%) of pa-
tients who were on HRT had undergone BSO. Perhaps this
is because standard HRT may be insufficient to replace the
full hormonal milieu produced by the ovary for some
women, and other endogenous hormones may play a part
in the female sexual response. For example, testosterone
production continues even in the postmenopausal ovary,
albeit at a markedly reduced rate [23]. A prospective, ran-
domized study of TAH/BSO patients showed that those
receiving combined testosterone and estrogen therapy
had greater sexual desire than women receiving estrogen
alone [24].
Menopausal status could have been directly determined
from our questionnaire although it was found that the
majority (71%) of patients greater than age 45 in the
study population underwent surgical menopause (BSO)
Orgasm frequency
same/better 31(94) 12(57)** 11.6 14(61) 29(94) 17(68) 26(90)
worse 2(6) 9(43) (2.2–61.8) 9(39) 2(6) 8(32) 3(10)
Overall sexual satisfication
same/better 31(94) 16(67)*** 7.8 17(65) 30(97)† 20(74) 27(90)
worse 2(6) 8(33) (1.5–40.9) 9(35) 1(3) 7(26) 3(10)
Data are presented as n(%) except OR (95%CI); Not all patients answered every question; *p = 0.01, **p = 0.03, ***p = 0.03, †p = 0.02, all others are 
not significant
Table 4: Sexual function results (Continued)BMC Women's Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/1
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and were taking HRT at the time of questionnaire comple-
tion.
Conclusion
In summary, we found that patients who underwent a
TAH experienced worse sexual outcome than SCH pa-
tients with respect to frequency of intercourse, frequency
of orgasm and overall sexual satisfaction. Our results sug-
gest that type of hysterectomy does predict overall postop-
erative sexual satisfaction. Adding in the consideration of
whether a BSO was performed significantly enhances this
prediction. Prospective studies are needed to confirm
these findings and determine the clinical impact that cer-
vical and ovarian conservation may have for the patient.
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